| Literature DB >> 34681034 |
Zhipeng Li1, Xinhui Song1, Shan Yin2, Jiageng Yan1, Peiru Lv2, Huiquan Shan1, Kuiqing Cui1, Hongbo Liu2, Qingyou Liu1.
Abstract
Donkeys are an important domesticated animal, providing labor, meat, milk, and medicinal materials for humans. However, the donkey population is continuously declining and even at risk of extinction. The application of modern animal production technology, such as oocyte in vitro maturation, is a promising method to improve the donkey population. In this study, we explore the gene expression patterns of donkey germinal vesicle (GV) and in vitro matured metaphase II (MII) oocytes using single cell RNA-seq of the candidate genes along with the regulatory mechanisms that affect donkey oocyte maturation. We identified a total of 24,164 oocyte genes of which 9073 were significant differentially expressed in the GV and MII oocytes. Further Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that these genes were associated with the meiotic cell cycle, mitochondrion activity, and N-glycan biosynthesis, which might be the key genes and regulatory mechanisms affecting the maturation of donkey oocytes. Our study provides considerable understanding regarding the maturation of donkey oocytes and serves as a theoretical basis for improving the development of donkey oocytes, which could ultimately benefit the expansion of the donkey population and conservation of biodiversity and genetic resources.Entities:
Keywords: donkey; gene expression; in vitro maturation; oocytes; single-cell RNA-seq
Mesh:
Year: 2021 PMID: 34681034 PMCID: PMC8535270 DOI: 10.3390/genes12101640
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Oocyte recovery from adult jenny ovaries by scraping.
| Repetitions | No. of Ovaries Per Experiment | No. of Oocytes Recovered | No. of Oocytes Per Ovaries |
|---|---|---|---|
| 1 | 48 | 361 | 7.52 |
| 2 | 45 | 291 | 6.47 |
| 3 | 48 | 365 | 7.60 |
| 4 | 55 | 445 | 8.09 |
| 5 | 33 | 230 | 6.96 |
| Total | 229 | 1692 | 7.33 ± 0.28 * |
Note: * The data are mean ± SEM from five replicates.
Nuclear maturation of donkey oocytes after in vitro culture.
| Oocytes Stage | No. of Oocytes (%) |
|---|---|
| GV | 1018 (63.68 ± 2.68 c) |
| MI | 150 (9.26 ± 1.18 a) |
| MII | 423 (27.08 ± 3.23 b) |
Note: All data are the mean ± SEM from five replicates. Different superscripts within the same column represent significant differences (p < 0.01).
Figure 1Transcriptional analysis of donkey oocytes at the GV and MII stage. (A). Collected donkey oocytes at the GV and MII stage for scRNA-seq. (B). Principal component analysis (PCA) of six samples based on gene expression. The red dots indicate GV oocytes, and the blue dots indicate MII oocytes. (C). Repeated relevance assessment of the transcriptomes of donkey oocytes. (D). The total mRNAs detected by scRNA-seq in GV and MII oocytes. (E). Overlap of the expressed genes identified in GV and MII oocyte.
The top 20 most abundantly expressed genes in the scRNA-seq profiles of each group.
| GV Group ( | MII Group ( | ||||
|---|---|---|---|---|---|
| Gene | Gene | Average | Gene | Gene | Average FPKM |
|
| Developmental Pluripotency-Associated Protein 3 | 20,656.8 |
| Developmental Pluripotency-Associated Protein 3 | 20,223.6 |
|
| Pituitary Tumor-Transforming 1 | 19,649.5 |
| Pituitary Tumor-Transforming 1 | 19,585.9 |
|
| 10,616.3 |
| 7462.3 | ||
|
| Growth Differentiation Factor 9 | 6493.5 |
| BTG Anti-Proliferation Factor 4 | 5170.7 |
|
| Ubiquitin B | 6060.0 |
| 5137.5 | |
|
| Anterior Gradient 2, Protein Disulphide Isomerase Family Member | 5435.3 |
| RAS Like Family 11 Member A | 4670.0 |
|
| 4559.9 |
| Karyopherin Subunit α 7 | 4645.6 | |
|
| Zona Pellucida Glycoprotein 3 | 4516.6 |
| CDC28 Protein Kinase Regulatory Subunit 1B | 4343.5 |
|
| CDC28 Protein Kinase Regulatory Subunit 1B | 4381.1 |
| 3948.4 | |
|
| Ring Finger Protein 34 | 3478.1 |
| Ring Finger Protein 34 | 3662.4 |
|
| BTG Anti-Proliferation Factor 4 | 3358.6 |
| Ubiquitin B | 3030.3 |
|
| Zygote Arrest 1 Like | 3323.5 |
| Zona Pellucida Glycoprotein 3 | 2997.1 |
|
| Arginase 2 | 3278.5 |
| WEE2 Oocyte Meiosis Inhibiting Kinase | 2327.4 |
|
| Karyopherin Subunit α 7 | 3226.7 |
| 2294.0 | |
|
| 2823.5 |
| CCHC-Type Zinc Finger Nucleic Acid Binding Protein | 2293.9 | |
|
| 2684.6 |
| Cyclin B1 | 2198.8 | |
|
| 2541.2 |
| Centromere Protein E | 2163.2 | |
|
| Bone Morphogenetic Protein 15 | 2472.0 |
| Growth Differentiation Factor 9 | 2068.7 |
|
| Calmodulin 2 | 1989.0 |
| Heterogeneous Nuclear Ribonucleoprotein A1 | 2042.1 |
|
| Replication Factor C Subunit 3 | 1935.0 |
| 1945.9 | |
Figure 2Differentially expressed gene (DEG) analysis. (A). Volcano plot for DEGs between GV and MII donkey oocytes (FDR < 0.05 and |log2 (fold change) | ≥ 1.5); The red dots represent upregulated genes, and the blue dots represent downregulated genes. (B). Bar chart showing the up-regulated DEGs and down-regulated DEGs. (C). Heatmap of all DEGs.
Top 10 genes with the highest and the lowest fold changes after oocyte in vitro maturation.
| Gene Symbol | Gene Name | Fold Change | |
|---|---|---|---|
|
| Galectin-3 | 7.94 | 1.42 × 10−20 |
|
| Tissue Factor Pathway Inhibitor 2 | 7.42 | 7.93 × 10−45 |
|
| Annexin A1 | 7.35 | 1.54 × 10−23 |
|
| S100 Calcium Binding Protein A11 | 5.99 | 2.95 × 10−15 |
|
| A-Kinase Anchoring Protein 2 | 5.86 | 4.08 × 10−34 |
|
| Actin γ 2, Smooth Muscle | 5.57 | 1.41 × 10−13 |
|
| Inhibin Subunit β A | 4.57 | 3.00 × 10−15 |
|
| 4.56 | 5.77 × 10−14 | |
|
| Vimentin | 3.91 | 8.33 × 10−5 |
|
| Cyclin D2 | 3.87 | 8.85 × 10−17 |
|
| ATP Synthase Membrane Subunit F | −7.52 | 3.40 × 10−23 |
|
| −7.32 | 1.52 × 10−16 | |
|
| FKBP Prolyl Isomerase 2 | −6.37 | 3.40 × 10−12 |
|
| Single-Pass Membrane Protein With Aspartate Rich Tail 1 | −6.33 | 7.50 × 10−12 |
|
| Tubulin β 4B Class IVb | −6.15 | 8.38 × 10−125 |
|
| −6.13 | 4.16 × 10−11 | |
|
| −6.08 | 3.44 × 10−55 | |
|
| Transmembrane Protein 11 | −6.06 | 4.10 × 10−25 |
|
| NADH: Ubiquinone Oxidoreductase Subunit A8 | −6.06 | 4.10 × 10−25 |
|
| −5.95 | 4.85 × 10−85 |
Figure 3GO enrichment of (A) up-regulated DEGs and (B) down-regulated DEGs with the top 10 terms in biological process, cellular component, and molecular function.
Figure 4KEGG enrichment of the top 20 (A) up-regulated and (B) down-regulated terms.
Figure 5Expression of glycosylation genes. (A). Heat map representation of DEGs belonging to the selected N-Glycan biosynthesis enriched by up-regulated DEGs. (B). Heat map representation of DEGs belonging to the selected mucin-type O-Glycan biosynthesis enriched by all DEGs.
Figure 6The expression of differentially expressed genes during oocyte maturation. ** indicates p < 0.01; and *** indicates p < 0.001.